First, the investigators identified parthenolide as a small molecule with activity in both the acute myeloid leukaemia (AML)-initiating cell and the bulk population of AML cells by both inhibiting NF-κB and inducing oxidative stress (Guzman et al, 2007). This evidence concerns the gene NFKB1 and acute myeloid leukemia.